Barclays PLC Abb Vie Inc. Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Barclays PLC holds 4,380,646 shares of ABBV stock, worth $851 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

4,380,646

Previous 3,795,259 15.42%

Holding current value

$851 Million

Previous $691 Million 8.72%

% of portfolio

0.23%

Previous 0.24%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $90.6 Million - $106 Million	585,387 Added 15.42%	4,380,646 $751 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $85.1 Million - $96.9 Million	532,338 Added 16.31%	3,795,259 $691 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $77.1 Million - $86.8 Million	-560,400 Reduced 14.66%	3,262,921 $506 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $27.5 Million - $31.9 Million	-205,961 Reduced 5.11%	3,823,321 $570 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $276 Million - $343 Million	2,079,578 Added 106.66%	4,029,282 $543 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $222 Million - $256 Million	-1,538,083 Reduced 44.1%	1,949,704 $311 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $99.7 Million - $120 Million	720,738 Added 26.05%	3,487,787 $564 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $132 Million - $152 Million	984,585 Added 55.24%	2,767,049 $371 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $135 Million - $172 Million	-981,234 Reduced 35.5%	1,782,464 $273 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $191 Million - $238 Million	-1,450,419 Reduced 34.42%	2,763,698 $448 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $36.5 Million - $46.2 Million	339,670 Added 8.77%	4,214,117 $571 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $99.6 Million - $113 Million	935,964 Added 31.85%	3,874,447 $418 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $71.4 Million - $79.6 Million	678,807 Added 30.04%	2,938,483 $331 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $30.4 Million - $33.5 Million	-297,379 Reduced 11.63%	2,259,676 $245 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $189 Million - $256 Million	-2,354,041 Reduced 47.93%	2,557,055 $274 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $255 Million - $299 Million	2,966,779 Added 152.59%	4,911,096 $430 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $18.9 Million - $25.3 Million	-257,799 Reduced 11.71%	1,944,317 $191 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $63.3 Million - $96 Million	-982,024 Reduced 30.84%	2,202,116 $168 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $45.3 Million - $56.6 Million	627,388 Added 24.54%	3,184,140 $282 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $37.1 Million - $44.6 Million	-589,451 Reduced 18.74%	2,556,752 $194 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $11.5 Million - $14.7 Million	175,509 Added 5.91%	3,146,203 $229 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $15.7 Million - $18.5 Million	-203,369 Reduced 6.41%	2,970,694 $239 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $167 Million - $206 Million	-2,142,557 Reduced 40.3%	3,174,063 $293 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $130 Million - $145 Million	1,464,592 Added 38.02%	5,316,620 $503 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $28.9 Million - $34.2 Million	321,933 Added 9.12%	3,852,028 $357 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $72 Million - $96.4 Million	782,425 Added 28.48%	3,530,095 $334 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $121 Million - $133 Million	1,352,790 Added 96.98%	2,747,670 $266 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $97.4 Million - $124 Million	1,394,880	1,394,880 $124 Million

Others Institutions Holding ABBV

# of Institutions

3,692

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $343B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account